Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases

This publication has 150 references indexed in Scilit:

• Can the Novel Aldosterone Inhibiting Drug Balcinrenone Reduce Hyperkalaemia and Worsening Renal Function Compared to Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure?
  European Journal of Heart Failure, 2024
• Balcinrenone Plus Dapagliflozin in Patients with Heart Failure and Chronic Kidney Disease: Results from the Phase 2b MIRACLE Trial
  European Journal of Heart Failure, 2024
• Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension
  JAMA, 2023
• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
  European Journal of Heart Failure, 2022
• Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside
  2016
• The Multifaceted Mineralocorticoid Receptor
  Comprehensive Physiology, 2014
• Long-term Renal Outcomes in Patients With Primary Aldosteronism
  JAMA, 2006
• Aldosterone Biosynthesis, Regulation, and Classical Mechanism of Action
  Heart Failure Reviews, 2005
• Induction of Cardiac Fibrosis by Aldosterone
  Journal of Molecular and Cellular Cardiology, 2000
• Spironolactone Metabolism: Steady‐State Serum Levels of the Sulfur‐Containing Metabolites
  The Journal of Clinical Pharmacology, 1989